These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 794978

  • 1. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M.
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J, Troncoso G, Costamaillere L, Rodríguez J.
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract] [Full Text] [Related]

  • 3. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG.
    Med J Aust; 1976 Mar 13; 1(11):343-5. PubMed ID: 775265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP, Wallace MG.
    Practitioner; 1977 Mar 13; 218(1305):431-4. PubMed ID: 322112
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R, Piazzini M, Conti C, Papi L, Strazzulla G, Matassi L.
    Clin Ter; 1987 Mar 15; 120(5):385-91. PubMed ID: 2953538
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS, Boshell BR.
    Curr Ther Res Clin Exp; 1975 Dec 15; 18(6):816-24. PubMed ID: 813947
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maziniol in the treatment of obesity.
    Sedgwick JP.
    Practitioner; 1975 Mar 15; 214(1281):418-20. PubMed ID: 1096123
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of the anorectic effect of mazindol and placebo in obesity].
    Tatoń J, Czech A, Koliński P, Podwysocka G.
    Pol Tyg Lek; 1979 Dec 10; 34(50):1967-70. PubMed ID: 395517
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M, Chlebna-Sokoł D, Mastalska A, Zwaigzne-Raczyńska J.
    Przegl Lek; 1981 Dec 10; 38(2):311-4. PubMed ID: 7017826
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind evaluation of mazindol in refractory obesity.
    Smith RG, Innes JA, Munro JF.
    Br Med J; 1975 Aug 02; 3(5978):284. PubMed ID: 1097046
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M, Chlebna-Sokół D, Kobierska I, Konopińska A, Małek M, Mastalska A, Zwaigzne-Raczyńska J.
    Przegl Lek; 1981 Aug 02; 38(3):355-8. PubMed ID: 7017827
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM, Howard AN.
    Int J Obes; 1977 Aug 02; 1(3):271-8. PubMed ID: 363631
    [Abstract] [Full Text] [Related]

  • 16. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R.
    Cas Lek Cesk; 1975 Feb 21; 114(8):249-54. PubMed ID: 1095197
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F.
    Med Welt; 1976 Oct 01; 27(40):1904-8. PubMed ID: 790077
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.